OA-57 Results of a Phase 1 Clinical Trial of Belantamab Mafadotin (belmaf) Combined with Carfilzomib, Lenalidomide, and Dexamethasone (krd) for Multiple Myeloma (MM) after One Prior Line of Therapy (LOT)
Clinical Lymphoma Myeloma and Leukemia(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要